EP2418205A1 — Pyrimidine urea derivatives as kinase inhibitors
Assigned to IRM LLC · Expires 2012-02-15 · 14y expired
What this patent protects
The invention relates to a process for the preparation of compounds of formula (1) and to intermediates used in the process, wherein the substituents X 1 , X, Y, Z, R 1 , R 2 and R 3 have the meaning as set forth and explained in the description of the invention.
USPTO Abstract
The invention relates to a process for the preparation of compounds of formula (1) and to intermediates used in the process, wherein the substituents X 1 , X, Y, Z, R 1 , R 2 and R 3 have the meaning as set forth and explained in the description of the invention.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.